Orhan Sezer
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 0.5%
- Bone health and treatments
- Peptidase Inhibition and Analysis
Papers in
- Oncology 76
- Peptidase Inhibition and Analysis 24
- Bone health and treatments 24
- Cancer Treatment and Pharmacology 13
-
- Ubiquitin and proteasome pathways 22
- Protein Degradation and Inhibitors 10
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
- Co-authors
- Ulrike Heider (59 shared papers)Christian Jakob (53 shared papers)Ivana Zavrski (33 shared papers)Kurt Possinger (36 shared papers)Martin Kaiser (40 shared papers)Jan Eucker (31 shared papers)Claudia Fleissner (28 shared papers)Jane Blazeby (11 shared papers)
- Journals
- Blood (25 papers)European Journal of Cancer (20 papers)European Journal Of Haematology (19 papers)Anti-Cancer Drugs (9 papers)Annals of Hematology (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Orhan Sezer
167 papers receiving 10.8k citations
Orhan Sezer's Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 3.6k
- Oncology 3.8k
- Genetics 833
- Molecular Biology 4.1k
- Pathology and Forensic Medicine 813
Countries citing papers authored by Orhan Sezer
This map shows the geographic impact of Orhan Sezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Sezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Sezer more than expected).
Fields of papers citing papers by Orhan Sezer
This network shows the impact of papers produced by Orhan Sezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Sezer. The network helps show where Orhan Sezer may publish in the future.
Co-authors
The 25 scholars most cited alongside Orhan Sezer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis Hit paper breakdown → | 2005 | 999 |
| 2 | 2009 | 326 | |
| 3 | 2003 | 322 | |
| 4 | 2009 | 307 | |
| 5 | 2009 | 306 | |
| 6 | 2013 | 243 | |
| 7 | 2011 | 228 | |
| 8 | 2003 | 194 | |
| 9 | 2002 | 187 | |
| 10 | 2007 | 182 | |
| 11 | 2004 | 175 | |
| 12 | 2005 | 174 | |
| 13 | 2003 | 168 | |
| 14 | 2009 | 167 | |
| 15 | 2007 | 160 | |
| 16 | 2018 | 159 | |
| 17 | 2008 | 156 | |
| 18 | 2007 | 153 | |
| 19 | 2001 | 150 | |
| 20 | 2010 | 150 |
About Orhan Sezer
Orhan Sezer is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Surgery, having authored 171 papers that have together received 11.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (63 papers), Peptidase Inhibition and Analysis (24 papers), Bone health and treatments (24 papers), Ubiquitin and proteasome pathways (22 papers), Cancer Treatment and Pharmacology (13 papers), Protein Degradation and Inhibitors (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (3.6k citations), Oncology (3.8k citations), Genetics (833 citations), Molecular Biology (4.1k citations) and Pathology and Forensic Medicine (813 citations). Orhan Sezer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ulrike Heider, Christian Jakob, Ivana Zavrski, Kurt Possinger, Martin Kaiser, Jan Eucker, Claudia Fleissner, Jane Blazeby, Evangelos Terpos and Thierry Conroy. Their work appears in journals such as Blood, European Journal of Cancer, European Journal Of Haematology, Anti-Cancer Drugs and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.